Iovance Biotherapeutics (IOVA) Return on Capital Employed [ROCE] (2010 - 2026)
Iovance Biotherapeutics (IOVA) reported Return on Capital Employed [ROCE] of -37.03% for Q2 2026, up 13.80 percentage points from -50.83% a year earlier and up 8.94 percentage points from the prior quarter.
Iovance Biotherapeutics (IOVA) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends
For FY2025, Iovance Biotherapeutics posted Return on Capital Employed [ROCE] of -52.15%, up 2.52 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a five-year change of +0.06 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -54.67% in FY2024 (+20.60 pp), -75.27% in FY2023 (-11.87 pp), -63.40% in FY2022 (-13.27 pp) and -50.13% in FY2021 (+2.09 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2020.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2023 (a gain of 15.87 percentage points); the low point was Q3 2022 (a drop of 38.22 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -45.97% (Q1 2026), -52.34% (Q4 2025) and -53.37% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | -27.18% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -27.18% |
| Jun 30, 2026 | -37.03% |
| Mar 31, 2026 | -45.97% |
| Dec 31, 2025 | -52.34% |
| Sep 30, 2025 | -53.37% |
| Jun 30, 2025 | -50.83% |
| Mar 31, 2025 | -48.88% |
| Dec 31, 2024 | -47.71% |
| Sep 30, 2024 | -50.01% |
| Jun 30, 2024 | -55.77% |
| Mar 31, 2024 | -63.01% |
| Dec 31, 2023 | -65.23% |
| Sep 30, 2023 | -62.53% |
| Jun 30, 2023 | -60.99% |
| Mar 31, 2023 | -63.62% |
| Dec 31, 2022 | -77.68% |
| Sep 30, 2022 | -78.39% |
| Jun 30, 2022 | -63.72% |
| Mar 31, 2022 | -54.19% |
| Dec 31, 2021 | -48.01% |
Iovance Biotherapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();